Symposium 01 (KASL) : Nov. 18 (Thu),08:30-10:00
- Distinguished Research of 2021 in Liver Disease

• Viral hepatitis Hyun Woong Lee
  Yonsei Univ., Korea CV 즐겨찾기
• Alcoholic and nonalcoholic liver disease Byoung Kuk Jang
  Keimyung Univ., Korea CV 즐겨찾기
• Liver cirrhosis and complications Byung Seok Kim
  Daegu Catholic Univ., Korea CV 즐겨찾기
• Hepatocellular carcinoma Jooho Lee
  CHA Univ., Korea CV 즐겨찾기

Memorial Lecture (KASL) : Nov. 18 (Thu),10:15-10:45
- Chung Yong Kim Memorial Lecture

• Beyond the best with humanity and creativity Kwang-Hyub Han
  National Evidence-based Healthcare Collaborating Agency (NECA), Korea CV 즐겨찾기

General Meeting : Nov. 18 (Thu),10:45-11:45

Symposium 03 (KASL) : Nov. 18 (Thu),12:25-13:55
- AI Application in Future Hepatology

• The application of texture quantification in hepatocellular carcinoma using CT and MRI Kwang Gi Kim
  Gachon Univ., Biomedical Engineering, Korea CV 즐겨찾기
• Next generation diagnostic pathology: Artificial intelligence-powered diagnosis and biomarker analysis Chan-Young Ock
  Lunit Inc., Korea CV 즐겨찾기
• Utilization of digital healthcare big data Young-Hak Kim
  Univ. of Ulsan, Cardiology, Korea CV 즐겨찾기
• Profiling based identification and application of non-coding RNAs as biomarker for hepatocellular carcinoma Keun Hur
  Kyungpook National Univ., Biochemistry and Cell Biology, Korea CV 즐겨찾기

Symposium 07 (KASL) : Nov. 18 (Thu),14:10-15:40
- Clinical Decision in Chronic Liver Diseases

• The assessment of NAFLD using diagnostic algorithm Dae Won Jun
  Hanyang Univ. Hosp., Korea CV 즐겨찾기
• The sequential application of systemic chemotherapy in advanced HCC Bo Hyun Kim
  National Cancer Center, Korea CV 즐겨찾기
• The treatment of nonselective beta blocker to patients with varices: (Who, When, and Which drug) Moon Young Kim
  Yonsei Univ. Wonju, Korea CV 즐겨찾기
• The selection of proper anti-viral agents to patients with CHB in each condition Jun Yong Park
  Yonsei Univ., Korea CV 즐겨찾기

Symposium 11 (KASL) : Nov. 18 (Thu),15:55-17:25
- Liver Disease and Vaccination

• The present and future of therapeutic vaccine for viral hepatitis B Kyun-Hwan Kim
  Sungkyunkwan Univ., Precision Medicine, Korea CV 즐겨찾기
• The present and future of therapeutic or preventative vaccine for viral hepatitis C Eui-Cheol Shin
  Korea Advanced Institute of Science and Technology, Korea CV 즐겨찾기
• COVID-19 vaccination in patients with chronic liver disease Jung Yeon Heo
  Ajou Univ., Infectious Diseases, Korea CV 즐겨찾기
• Vaccination strategy for patients with chronic liver disease and liver transplantation Eunjung Lee
  Soonchunhyang Univ., Infectious Diseases, Korea CV 즐겨찾기

KASL-AASLD Joint Symposium 01 (KASL) : Nov. 19 (Fri),08:30-10:00
- COVID-19 and the Management of Chronic Liver Diseases

• Pathogenesis and outcomes of COVID-19 in patients with chronic liver disease Andrew Moon
  Univ. of North Carolina, USA CV 즐겨찾기
• COVID-19 in liver transplantation Elizabeth C. Verna
  Columbia Univ., USA CV 즐겨찾기
• COVID-19 vaccination for patients with chronic liver diseases Won Suk Choi
  Korea Univ., Infectious Diseases, Korea CV 즐겨찾기

KASL-AASLD Joint Symposium 02 (KASL) : Nov. 19 (Fri),10:15-11:45
- Recent Update of Fatty Liver Disease

• A unique phenotype of NAFLD: NAFLD with sarcopenia Won Kim
  Seoul National Univ., Korea CV 즐겨찾기
• Recent updates of clinical trials on NASH Mary Eugenia Rinella
  The Univ. of Chicago, USA CV 즐겨찾기
• Influence of NAFLD on chronic hepatitis B and C Seung Up Kim
  Yonsei Univ., Korea CV 즐겨찾기

KASL-AASLD Joint Symposium 03 (KASL) : Nov. 19 (Fri),12:25-13:55
- Changes in the Management of Chronic Hepatitis B

• Artificial intelligence-driven HCC prediction model for patients with chronic hepatitis B Hwi Young Kim
  Ewha Womans Univ., Korea CV 즐겨찾기
• Expanding treatment criteria for chronic hepatitis B Young-Suk Lim
  Univ. of Ulsan, Korea CV 즐겨찾기
• Recent updates of clinical trials on functional cure of chronic hepatitis B W Ray Kim
  Stanford Univ., USA CV 즐겨찾기

Basic/Translational Symposium 04 (KASL) : Nov. 19 (Fri),14:10-15:40
- Basic Science Forum of Liver Disease: Metabolic Approaches for the Translational Medicine of Liver Diseases

• Small intestinal dietary fructose metabolism prevents non-alcoholic fatty liver disease Cholsoon Jang
  Univ. of California, Irvine, USA CV 즐겨찾기
• Microbial metabolites entering into the liver: The role in diabetes and drug responses Ara Koh
  POSTECH, Korea CV 즐겨찾기
• Fructose modulates leaky gut, endotoxemia and liver fibrosis through CYP2E1-mediated oxidative and Nitrative stress Young-Eun Cho
  Andong National Univ., Food and Nutrition, Korea CV 즐겨찾기
• Role of diabetes on the risk of hepatocellular carcinoma in cirrhosis patients with NAFLD Ju Dong Yang
  Cedars-Sinai Medical Center, USA CV 즐겨찾기

Multidisciplinary Session 02 (KASL) : Nov. 19 (Fri),15:55-17:25
- Comprehensive Multidisciplinary Approach for Obesity and/or NAFLD

• Clinical significance of obese and non-obese Fatty Liver Disease Jeongju Yoo
  Soonchunhyang Univ., Korea CV 즐겨찾기
• Radiological assessment of NAFLD Dong Ho Lee
  Seoul National Univ., Radiology, Korea CV 즐겨찾기
• Endoscopic therapies for obesity in NAFLD Seung-Joo Nam
  Kangwon National Univ., Korea CV 즐겨찾기
• Bariatric surgery in the management of obesity in NAFLD Jong-Han Kim
  Korea Univ., Surgery, Korea CV 즐겨찾기

PG Course 05 (KASL) : Nov. 20 (Sat),08:30-10:00
- Updated KASL Practice Guideline of NAFLD

• Definition, epidemiology, and co-morbidities: Focusing on the changes Sang Gyune Kim
  Soonchunhyang Univ., Korea CV 즐겨찾기
• Diagnostic algorithm for identifying high-risk patients in NAFLD Sang Bong Ahn
  Eulji Univ., Korea CV 즐겨찾기
• Updates on non-invasive assessment of liver steatosis and fibrosis Hye Won Lee
  Yonsei Univ., Korea CV 즐겨찾기
• Current and future pharmacological and surgical treatment options Yuri Cho
  National Cancer Center, Korea CV 즐겨찾기